EcoR1 Capital’s Repare Therapeutics RPTX Stock Holding History

EcoR1 Capital’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50,000	Closed	-$712K	–	93
2022 Q1	$712K	Hold	50,000	–	–	0.02%	79
2021 Q4	$1.05M	Hold	50,000	–	–	0.03%	65
2021 Q3	$1.29M	Hold	50,000	–	–	0.04%	60
2021 Q2	$1.56M	Hold	50,000	–	–	0.06%	61
2021 Q1	$1.53M	Hold	50,000	–	–	0.07%	60
2020 Q4	$1.72M	Hold	50,000	–	–	0.09%	58
2020 Q3	$1.54M	Hold	50,000	–	–	0.11%	43
2020 Q2	$1.55M	Buy	+50,000	New	+$1.61M	0.11%	43

Other funds holding RPTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

EcoR1 Capital's RPTX Position: Q2 2022 in Review

EcoR1 Capital sold out of Repare Therapeutics (RPTX) in Q2 2022, closing a stake of 50,000 shares — an estimated $712K sold.

EcoR1 Capital first reported a position in RPTX in Q2 2020 and held it in 8 quarters. The position peaked at $1.72M in Q4 2020. 71 funds tracked by Wall St. Rank hold RPTX as of Q2 2022.

EcoR1 Capital reported no remaining Repare Therapeutics position as of Q2 2022 after selling out during the quarter.
EcoR1 Capital sold 50,000 Repare Therapeutics shares in Q2 2022, an estimated $712K.
EcoR1 Capital first reported a position in Repare Therapeutics in Q2 2020 and held it in 8 quarters.
EcoR1 Capital's Repare Therapeutics position peaked at $1.72M in Q4 2020.
71 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2022.

Based on EcoR1 Capital's 13F filing for Q2 2022, filed 15 Aug 2022.